The 2nd Annual Meeting of the International Academy for Clinical Hematology (IACH)
Les Salons De L’Aveyron

Paris, France
The 2nd Annual Meeting of the International Academy for Clinical Hematology (IACH)
CME Congresses
Les Salons De L’Aveyron

Schedule of Presentations:

Thursday, September 19, 2019
06:00:00 New Presentation
09:00:00 Session F1B: Allogeneic stem cell transplant indications and results Jordi Sierra, Ibrahim Yakoub-Agha
09:00:00 Acute lymphoblastic leukemia Sebastian Giebel
09:00:00 Management of elderly myeloma Thierry Facon
09:20:00 Management of transplant-eligible myeloma Mohamad Mohty
09:40:00 Management of extra-medullary and high-risk myeloma
10:00:00 Relapsed myeloma Meral Beksaç
13:30:00 New PresentationHematology hot news session: advances in disease biology Arnon Nagler, Irene Ghobrial
13:30:00 Introduction to IACH activities and projects Arnon Nagler, Mohamad Mohty
14:00:00 Waldenstrom macroglobulinemia Irene Ghobrial
14:40:00 Myelodysplastic syndromes Ghulam Mufti
15:00:00 Multiple myeloma Robert Orlowski
15:20:00 ITP Jenny Despotovic
16:00:00 Current recommendation for TKI cessation in chronic myeloid leukemia (CML) F François Guilhot
16:00:00 Plenary Session 1: Advances in hematology He Huang, Mohamad Mohty
16:20:00 CAR T cells: experience from China He Huang
16:20:00 New insights in NPM1-1 mutated AML Brunangelo Falini
16:40:00 Next generation CAR T cells Saad Kenderian
17:00:00 Chronic lymphocytic leukemia: state-of-the-art therapy Gianluca Gaidano
17:30:00 Short Break
17:45:00 Opening Session: Keynote opening lecture and award presentation Arnon Nagler, Mohamad Mohty
17:45:00 Presentation of the H.J. Khoury excellence in research award
18:00:00 Management of elderly myeloma: 30 years of active research Thierry Facon
18:30:00 Welcome Reception
Friday, September 20, 2019
06:00:00 New Presentation Thomas Prebet
06:00:00 New Presentation
06:00:00 New Presentation
06:00:00 New Presentation
09:00:00 Session F1A: Multiple myeloma Meral Beksaç, Thierry Facon
09:20:00 Acute myeloid leukemia Arnon Nagler
09:40:00 Myelodysplastic syndromes Ibrahim Yakoub-Agha
10:00:00 Myeloproliferative neoplasms Naveen Pemmaraju
10:20:00 Discussion
10:20:00 Discussion
10:30:00 Short Break
10:45:00 Driving a change in outcomes for high-risk AML* and hepatic veno-occlusive disease *High-risk AML defined as therapy-related AML (t-AML) or AML with myelodysplasia-related changes (AML-MRC) Industry-supported Lunch Symposium (Hall A)
12:15:00 Lunch Break
12:45:00 APL
12:45:00 Management of CMV infections Rafael Duarte
13:05:00 Late events after reduced-intensity conditioning Avichai Shimoni
13:05:00 Risk stratification in AML
13:25:00 Coronary and artery disease Minoo Battiwalla
13:25:00 Management of elderly AML Thomas Prebet
13:45:00 Management of young AML (outside transplant Jordi Sierra
13:45:00 Long-term complications after HCT Minoo Battiwalla
14:05:00 Discussion
14:05:00 Discussion
14:15:00 Break, Poster Viewing and Visit Exhibition
14:45:00 Mantle cell lymphoma Olivier Hermine
14:45:00 Session F3A: Non-Hodgkin lymphoma MA Kharfan-Dabaja
14:45:00 Endothelium-related complications
15:05:00 High-grade lymphoma Christian Gisselbrecht
15:05:00 How I prevent GVHD
15:25:00 Indolent lymphoma Olivier Hermine
15:25:00 Therapy of acute GVHD Ernst Holler
15:45:00 Chronic lymphocytic leukemia MA Kharfan-Dabaja
15:45:00 Challenges in chronic GVHD clinical trials Iskra Pusic
16:05:00 Discussion
16:05:00 Discussion
16:15:00 Coffee Break, Poster Viewing and Visit Exhibition
16:30:00 CAR T cells in ALL
16:30:00 Session F4B: Advances in allogeneic stem cell transplantation Avichai Shimoni, Didier Blaise
16:30:00 Session F4A: Acute lymphoblastic leukemia (ALL) Sebastian Giebel , Hagop Kantarjian
16:50:00 Conditioning for haplo-identical transplantation Didier Blaise
16:50:00 Novel antibodies in relapsed/refractory ALL
17:10:00 Which intensity of therapy is required in ALL? Dieter Hoelzer
17:30:00 Management of elderly ALL Hagop Kantarjian
17:50:00 Discussion
18:00:00 How to write a good paper
18:00:00 Current status in CLL Ilaria Del Giudice
18:00:00 Session F5B: Case report forum Michael Byrne, Mohamad Mohty
18:20:00 Current status in AML Christopher Hourigan
18:20:00 A complex transplant case (1) Jean El-Cheikh
18:30:00 A complex transplant case (2)
18:40:00 Barriers to clinical trial enrollment in HSCT Michael Byrne
18:40:00 Current status in ALL
18:50:00 Discussion
Saturday, September 21, 2019
06:00:00 New Presentation
08:00:00 Session S1A: Transfusion medicine and haemostasis
08:00:00 Session S1B: Red blood cell disorders Ali Taher
09:00:00 Session S2A: Platelet disorders Stephane Giraudier, James B. Bussel
09:00:00 Session S2A: Platelet disorders Stephane Giraudier, James B. Bussel
09:00:00 Session S2B: Iron-related disorders Ali Taher
10:30:00 Session S3A: Management of aplastic anemia, MDS and sAML Elena Solomou, Thomas Cluzeau
10:30:00 Session S3B: Toxicities in HSCT Britta Engelhardt, Navneet Majhail
11:45:00 CAR T cells in lymphoid malignancies: current status and perspectives Non-profit Lunch Symposium (Hall A)
13:15:00 Session S4A: Management of Hodgkin lymphoma and rare T cell NHLs Owen A. O’Connor, A Bazarbachi
14:45:00 Session S5B: Making the right diagnosis in hematology Elad Jacoby
14:45:00 Session S5A: Clinical experiences from around the world Shinichiro Okamoto
16:15:00 Coffee Break, Poster Viewing and Visit Exhibition
16:45:00 Plenary Session 2: State-of-the-art management of … Anas Younes, Jean-Luc Harousseau
3D Tissue Models
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.